BioSpace News Archive

Kintara Therapeutics, Inc. (Nasdaq: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced today that its Chief Executive Officer Saiid Zarrabian will participate at the Benzinga Global Small Cap Conference on May 14, 2021 .

Delivers patient satisfaction*¹ and improved engagement¹ by allowing patients to do physical therapy at home, on demand and without using wearable sensors

Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced its quantitative COVID-19 IgG antibody test achieved CE Mark.

Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced that Pipette™, its clean baby and mothers skincare brand, will partner with non-profit organization, Baby2Baby to donate 200,000 units of its award-winning hand sanitizer to families living in poverty nationwide.

– Q1 2021 marked by solid operational execution with expansion and diversification of pipeline , intellectual property and portfolio of assets – P ivotal Phase 3 DET ECT (Study P02) safety and efficacy study evaluating macimorelin diagnostic for CGHD on track to commence in Q2 2021 – Strong balance sheet with cash expected to fund operations beyond 2023

Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced that the Company, through its subsidiary Gansu Qilianshan Pharmaceutical Co., Ltd., has entered into an exclusive agency agreement (the “Agreement”) with Henan Kangzhiyuan Pharmaceutical Co., Ltd.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today published its 2020 Environmental, Social and Governance (ESG) Progress Report detailing the company’s efforts to advance health and equity, minimize its impact on the planet and dedicate itself to quality, ethics and transparency.

OcuTerra Therapeutics, Inc. (“OcuTerra”), a clinical stage ophthalmology drug development company focused on treating diabetic retinopathy earlier to preserve vision and avoid intravitreal injections, today announced the appointment of Brent Saunders, Robert Ruffolo, Ph.D., and Robin Steele to its Board of Directors

Affinivax, Inc. (“Affinivax”), a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS™ (Multiple Antigen Presenting System) platform , today announced that Elizabeth Radcliffe has joined the company as Chief Financial Officer.

$38.1M in Rubraca ® (rucaparib) global net product revenues for Q1 2021, down 11% vs. Q1 2020, due to continued headwinds from COVID-19 in the US and Europe Maintained US market share as US PARP inhibitor market impacted by COVID-19 Imaging and treatment INDs cleared by FDA for FAP-2286, a novel peptide-targeted radionuclide therapy (PTRT) T